These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23597109)

  • 21. Effect of Citalopram on Emotion Processing in Humans: A Combined 5-HT
    Selvaraj S; Walker C; Arnone D; Cao B; Faulkner P; Cowen PJ; Roiser JP; Howes O
    Neuropsychopharmacology; 2018 Feb; 43(3):655-664. PubMed ID: 28776580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beyond negative valence: 2-week administration of a serotonergic antidepressant enhances both reward and effort learning signals.
    Scholl J; Kolling N; Nelissen N; Browning M; Rushworth MF; Harmer CJ
    PLoS Biol; 2017 Feb; 15(2):e2000756. PubMed ID: 28207733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute serotonin 2A receptor blocking alters the processing of fearful faces in the orbitofrontal cortex and amygdala.
    Hornboll B; Macoveanu J; Rowe J; Elliott R; Paulson OB; Siebner HR; Knudsen GM
    J Psychopharmacol; 2013 Oct; 27(10):903-14. PubMed ID: 23824248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroticism modulates amygdala-prefrontal connectivity in response to negative emotional facial expressions.
    Cremers HR; Demenescu LR; Aleman A; Renken R; van Tol MJ; van der Wee NJ; Veltman DJ; Roelofs K
    Neuroimage; 2010 Jan; 49(1):963-70. PubMed ID: 19683585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of acute citalopram on face emotion processing in remitted depression: a pharmacoMRI study.
    Anderson IM; Juhasz G; Thomas E; Downey D; McKie S; Deakin JF; Elliott R
    Eur Neuropsychopharmacol; 2011 Jan; 21(1):140-8. PubMed ID: 20599362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional brain responses to emotional faces after three to five weeks of intake of escitalopram in healthy individuals: a double-blind, placebo-controlled randomised study.
    Armand S; Langley C; Johansen A; Ozenne B; Overgaard-Hansen O; Larsen K; Jensen PS; Knudsen GM; Sahakian BJ; Stenbæk DS; Fisher PM
    Sci Rep; 2024 Feb; 14(1):3149. PubMed ID: 38326352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fronto-limbic effective connectivity as possible predictor of antidepressant response to SSRI administration.
    Vai B; Bulgarelli C; Godlewska BR; Cowen PJ; Benedetti F; Harmer CJ
    Eur Neuropsychopharmacol; 2016 Dec; 26(12):2000-2010. PubMed ID: 27756525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do You Believe It? Verbal Suggestions Influence the Clinical and Neural Effects of Escitalopram in Social Anxiety Disorder: A Randomized Trial.
    Faria V; Gingnell M; Hoppe JM; Hjorth O; Alaie I; Frick A; Hultberg S; Wahlstedt K; Engman J; Månsson KNT; Carlbring P; Andersson G; Reis M; Larsson EM; Fredrikson M; Furmark T
    EBioMedicine; 2017 Oct; 24():179-188. PubMed ID: 29033138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of citalopram and escitalopram on fMRI response to affective stimuli in healthy volunteers selected by serotonin transporter genotype.
    Henry ME; Lauriat TL; Lowen SB; Churchill JH; Hodgkinson CA; Goldman D; Renshaw PF
    Psychiatry Res; 2013 Sep; 213(3):217-24. PubMed ID: 23845563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neural correlates of perception of emotional facial expressions in out-patients with mild-to-moderate depression and anxiety. A multicenter fMRI study.
    Demenescu LR; Renken R; Kortekaas R; van Tol MJ; Marsman JB; van Buchem MA; van der Wee NJ; Veltman DJ; den Boer JA; Aleman A
    Psychol Med; 2011 Nov; 41(11):2253-64. PubMed ID: 21557888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spatiotemporal brain activation pattern following acute citalopram challenge is dose dependent and associated with neuroticism: A human phMRI study.
    Edes AE; McKie S; Szabo E; Kokonyei G; Pap D; Zsombok T; Hullam G; Gonda X; Kozak LR; McFarquhar M; Anderson IM; Deakin JFW; Bagdy G; Juhasz G
    Neuropharmacology; 2020 Jun; 170():107807. PubMed ID: 31593709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Augmenting serotonin neurotransmission with citalopram modulates emotional expression decoding but not structural encoding of moderate intensity sad facial emotional stimuli: an event-related potential (ERP) investigation.
    Labuschagne I; Croft RJ; Phan KL; Nathan PJ
    J Psychopharmacol; 2010 Aug; 24(8):1153-64. PubMed ID: 18832432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short-term antidepressant administration reduces negative self-referential processing in the medial prefrontal cortex in subjects at risk for depression.
    Di Simplicio M; Norbury R; Harmer CJ
    Mol Psychiatry; 2012 May; 17(5):503-10. PubMed ID: 21358707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for modulation of facial emotional processing bias during emotional expression decoding by serotonergic and noradrenergic antidepressants: an event-related potential (ERP) study.
    Kerestes R; Labuschagne I; Croft RJ; O'Neill BV; Bhagwagar Z; Phan KL; Nathan PJ
    Psychopharmacology (Berl); 2009 Mar; 202(4):621-34. PubMed ID: 18825371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. General and anxiety-linked influences of acute serotonin reuptake inhibition on neural responses associated with attended visceral sensation.
    Livermore JJA; Skora LI; Adamatzky K; Garfinkel SN; Critchley HD; Campbell-Meiklejohn D
    Transl Psychiatry; 2024 Jun; 14(1):241. PubMed ID: 38844469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of 5-HTTLPR on acute serotonin transporter blockade by escitalopram on emotion processing: preliminary findings from a randomised, crossover fMRI study.
    Outhred T; Das P; Dobson-Stone C; Felmingham KL; Bryant RA; Nathan PJ; Malhi GS; Kemp AH
    Aust N Z J Psychiatry; 2014 Dec; 48(12):1115-25. PubMed ID: 24810870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erythropoietin modulates neural and cognitive processing of emotional information in biomarker models of antidepressant drug action in depressed patients.
    Miskowiak KW; Favaron E; Hafizi S; Inkster B; Goodwin GM; Cowen PJ; Harmer CJ
    Psychopharmacology (Berl); 2010 Jun; 210(3):419-28. PubMed ID: 20401747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin Regulation of Amygdala Response to Threat in High-Trait-Anxiety Individuals.
    Reinecke A; Browning M; Klein Breteler J; Kappelmann N; Ressler KJ; Harmer CJ; Craske MG
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2018 Oct; 3(10):826-835. PubMed ID: 29980493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-term antidepressant treatment and facial processing. Functional magnetic resonance imaging study.
    Norbury R; Mackay CE; Cowen PJ; Goodwin GM; Harmer CJ
    Br J Psychiatry; 2007 Jun; 190():531-2. PubMed ID: 17541115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two-week treatment with the selective serotonin reuptake inhibitor citalopram reduces contextual anxiety but not cued fear in healthy volunteers: a fear-potentiated startle study.
    Grillon C; Chavis C; Covington MF; Pine DS
    Neuropsychopharmacology; 2009 Mar; 34(4):964-71. PubMed ID: 18800069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.